Human pharmacokinetic data on the new antiparasitic agent, ivermectin, are scanty. For the evaluation of its disposition a specific HPLC assay with sensitive fluorescence detection was developed. Applying equilibrium dialysis, plasma protein binding of ivermectin was measured in five healthy individuals and it averaged 93.2±4.4\% (SD). Such strong binding should be taken into consideration, especially in patients with malnutrition or with diseases in which a decrease in plasma proteins and consequently a higher free fraction of ivermectin could be expected.
Description
Ivermectin binds avidly to plasma proteins | SpringerLink
%0 Journal Article
%1 klotz1990ivermectin
%A Klotz, U.
%A Ogbuokiri, J. E.
%A Okonkwo, P. O.
%D 1990
%J European Journal of Clinical Pharmacology
%K ivermectin plasma_proteins
%N 6
%P 607--608
%R 10.1007/BF00316107
%T Ivermectin binds avidly to plasma proteins
%U https://doi.org/10.1007/BF00316107
%V 39
%X Human pharmacokinetic data on the new antiparasitic agent, ivermectin, are scanty. For the evaluation of its disposition a specific HPLC assay with sensitive fluorescence detection was developed. Applying equilibrium dialysis, plasma protein binding of ivermectin was measured in five healthy individuals and it averaged 93.2±4.4\% (SD). Such strong binding should be taken into consideration, especially in patients with malnutrition or with diseases in which a decrease in plasma proteins and consequently a higher free fraction of ivermectin could be expected.
@article{klotz1990ivermectin,
abstract = {Human pharmacokinetic data on the new antiparasitic agent, ivermectin, are scanty. For the evaluation of its disposition a specific HPLC assay with sensitive fluorescence detection was developed. Applying equilibrium dialysis, plasma protein binding of ivermectin was measured in five healthy individuals and it averaged 93.2{\textpm}4.4{\%} (SD). Such strong binding should be taken into consideration, especially in patients with malnutrition or with diseases in which a decrease in plasma proteins and consequently a higher free fraction of ivermectin could be expected.},
added-at = {2022-05-12T14:37:11.000+0200},
author = {Klotz, U. and Ogbuokiri, J. E. and Okonkwo, P. O.},
biburl = {https://www.bibsonomy.org/bibtex/2a15c36450637c9e764c42470dc33f8d3/fordham1},
day = 01,
description = {Ivermectin binds avidly to plasma proteins | SpringerLink},
doi = {10.1007/BF00316107},
interhash = {a8d8a0215e550bf0041c1ff15a61b2ab},
intrahash = {a15c36450637c9e764c42470dc33f8d3},
issn = {1432-1041},
journal = {European Journal of Clinical Pharmacology},
keywords = {ivermectin plasma_proteins},
month = dec,
number = 6,
pages = {607--608},
timestamp = {2022-05-12T14:37:11.000+0200},
title = {Ivermectin binds avidly to plasma proteins},
url = {https://doi.org/10.1007/BF00316107},
volume = 39,
year = 1990
}